Abstract
Translational cancer research requires a quality-of-life–driven agenda.
- Copyright © 2016, American Association for the Advancement of Science
EditorialPATIENT ADVOCACY
Enhancing quality of life as a goal for anticancer therapeutics
- Syril D. Pettit,
- Steven E. Lipshultz,
- Charles S. Cleeland,
- Samantha Roberts,
- Myrtle Davis,
- Brian R. Berridge and
- Rebecca A. Kirch
- Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit{at}hesiglobal.org
- Steven E. Lipshultz is Pediatrician-in-Chief of Children’s Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children’s Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.
- Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.
- Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.
- Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.
- Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA.
All authors are members of the HESI Thrive Advisory Board.
See allHide authors and affiliations
Science Translational Medicine 22 Jun 2016:
Vol. 8, Issue 344, pp. 344ed9
DOI: 10.1126/scitranslmed.aag0382
Vol. 8, Issue 344, pp. 344ed9
DOI: 10.1126/scitranslmed.aag0382
Syril D. Pettit
Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.org
Steven E. Lipshultz
Charles S. Cleeland
Samantha Roberts
Myrtle Davis
Brian R. Berridge
